The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hilar Cholangiocarcinoma: Current Management
Abstract
In Brief Objective: To review the literature with regard to outcome of surgical management for hilar cholangiocarcinoma (Klatskin tumor). Background: Hilar cholangiocarcinoma is a rare tumor with a poor prognosis. Surgical resection provides the only possibility for cure. Advances in hepatobiliary imaging and surgical strategies to treat this disease have resulted in improved postoperative outcomes. Methods: We performed a review of the English literature on hilar cholangiocarcinoma from 1990 to 2007. This review included preoperative evaluation, surgical techniques, issues and controversies in management, prognostic variables, and considerations for future directions. Results: Complete resection remains the most effective and only potentially curative therapy for hilar cholangiocarcinoma. Negative resection margins are associated with improved outcomes, and major hepatic resections have enhanced the likelihood of R0 resection. Portal vein embolization may be indicated in selected patients before extensive hepatic resection. Staging laparoscopy should be considered to detect occult metastatic disease. Orthotopic liver transplantation might be applicable for a highly selected subgroup. Conclusions: Surgical resection including major hepatic resection remains the mainstay of treatment of hilar cholangiocarcinoma. Additional evidence is needed to fully define the role of orthotopic liver transplantation. Improvements in adjuvant therapy are essential for improving long-term outcome. Current management of hilar cholangiocarcinoma was reviewed. Surgical resection including major hepatic resection remains the mainstay of treatment of hilar cholangiocarcinoma. Additional evidence is needed to fully define the role of orthotopic liver transplantation. Improvements in adjuvant therapy are essential for improving long-term outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma
Anderson, C. D., Rice, M. H., Pinson, C. W., Chapman, W. C., Chari, R. S., & Delbeke, D. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.10.003 · Cited by 377 · cited 1×
“The results of PET must be interpreted with caution in patients with primary sclerosing cholangitis or with biliary stents in place, as false positives often result.(33)”
Background
Cited by
Miyazaki, M., Yoshitomi, H., Miyakawa, S., Uesaka, K., Unno, M., Endo, I., Ota, T., Ohtsuka, M., Kinoshita, H., Shimada, K., et al. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.233 · Cited by 298
Nuzzo, G. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.771 · Cited by 275
Metadata
- Authors
- Ito, F., Cho, C. S., Rikkers, L. F., & Weber, S. M.
- Venue
- Annals of Surgery
- Published
- 2009-08
- Volume
- 250
- Issue
- 2
- Pages
- 210-218
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2061736521
- Cited by
- 241
- References
- 1
- FWCI
- 19.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hilar Cholangiocarcinoma: Current Management. https://app.cochat.ai/papers/10.1097/sla.0b013e3181afe0ab
- The paper
- Ito, F., Cho, C. S., Rikkers, L. F., & Weber, S. M. (2009). Hilar Cholangiocarcinoma: Current Management. Annals of Surgery. https://doi.org/10.1097/sla.0b013e3181afe0ab
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.